NEW YORK (GenomeWeb News) - The German Resource Center for Genome Research (RZPD), based in Berlin, said it has expanded an agreement with NimbleGen to cover Affymetrix’ microarray patents in Germany and Austria.
NimbleGen signed an agreement with Affymetrix in October that gave it non-exclusive, worldwide rights for the manufacture, use, and sale of nucleic acid microarrays.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.